Active Chicago clinical trials critical to minorities

Per the Cook County Health & Hospital Systems (CCH) FY23 – 25 Strategic Plan on Disproportionate Impact requiring CCH Focus:

  • Black men have the highest rate of prostate cancer deaths, more than twice as high as any other group.
  • Hispanic man and women are almost twice as likely to have and die from liver cancer.
  • Hispanic women are 40 percent more likely to be diagnosed with and 30 percent more likely to die from cervical cancer, compared to non-Hispanic women.

  • In 2017, Black men and women were nearly two and a half times more likely to be hospitalized for lower limb amputations related to diabetes compared to non-Hispanic whites.

  • In 2018, African Americans were 30 percent more likely to die from heart disease than non-Hispanic whites.

  • African American women are nearly 60 percent more likely to have high blood pressure compared to non-Hispanic white women.

  • Of African American women ages 20 and older, 49 percent have heart disease.

  • Black men are 70 percent more likely to die from a stroke compared to non-Hispanic whites.

Below are links to Chicago metropolitan area clinical trials that are currently in the recruiting stages that focus on the conditions targeted by the Cook County Health & Hospital System that disproportionately affect Hispanics/Latinos and African Americans. 

If you find a trial that is of interest, the American Cancer Society has guidance to learn more about being a participant with the options to read a variety of articles or watch a series of videos.  

Prostate Cancer

Liver Cancer

Cervical Cancer



Heart Disease